Literature DB >> 23473714

Influenza and RSV make a modest contribution to invasive pneumococcal disease incidence in the UK.

Emily J Nicoli1, Caroline L Trotter, Katherine M E Turner, Caroline Colijn, Pauline Waight, Elizabeth Miller.   

Abstract

OBJECTIVES: The common seasonality of incidence of invasive pneumococcal disease (IPD) and viral respiratory infections has long been recognized, however, the extent to which this affects the association between the pathogens is unknown. We have analysed weekly surveillance data of IPD, influenza and respiratory syncytial virus (RSV), using ambient temperature and hours of sunshine as measures of seasonality.
METHODS: Reported cases of influenza, IPD and RSV, were collected in England and Wales, from week 1 (January) 1996 to week 23 (June) 2009. The associations between IPD and respiratory viral infections were analysed using several statistical methods, including correlation coefficients and both additive and multiplicative regression models.
RESULTS: 6-7.5% of cases of IPD are attributable to influenza and 3-4% attributable to RSV. Correlation coefficients reported considerably stronger associations between IPD and the viral infections compared to regression models.
CONCLUSIONS: A small but potentially important percentage of IPD may be attributable to influenza and RSV when adjusted for seasonality by temperature. Jointly these viral infections may lead to over 10% of IPD cases. Therefore, prevention of viral respiratory infections may offer some additional benefit in reducing invasive pneumococcal infections.
Copyright © 2013 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23473714      PMCID: PMC3650581          DOI: 10.1016/j.jinf.2013.02.007

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


Introduction

The synergism between viral and bacterial infections has been widely reported, particularly for respiratory viruses and secondary bacterial pneumonia; however, the underlying mechanisms are complex and remain largely unknown. Respiratory infections, such as influenza, respiratory syncytical virus (RSV) and Streptococcus pneumoniae, show strong seasonal patterns, each having increased incidence in winter in temperate areas of the world. Temperature, humidity, pollution, light intensity and increased crowding in winter have all been suggested as factors in causing the annual fluctuations in disease incidence. Despite many studies and the use of multiple statistical techniques, the strength of association between invasive pneumococcal disease (IPD) and respiratory viral infections remains unclear. There has been a recent resurgence in interest in the relationship between IPD and influenza in the context of contemporary pandemic influenza preparedness and the use of the pneumococcal vaccines as an additional measure to prevent mortality. At a population level, several studies of surveillance data, outside of influenza pandemics, have sought to measure the associations between influenza, RSV and IPD. The reported strength of these associations varies between the studies, and appears to depend, at least partially, on the quantity of data available as well as the methods used. Even within the same data sample, the use of different statistical methods can lead to wildly different results. The associations are particularly difficult to measure because the common seasonality of the pathogens causes an overestimation of the result. A review of studies that have reported associations between IPD and influenza or RSV and their results can be found in the Supplementary Material. We have conducted a novel analysis of IPD, influenza and RSV surveillance data from England and Wales, using a range of statistical methods, in order to estimate the proportion of IPD cases that are attributable to respiratory viruses, whilst attempting to account for the common seasonality of the pathogens.

Methods

Source of data

Clinically significant isolates of influenza, invasive pneumococcal disease (IPD) and respiratory syncytial virus (RSV) are recorded by microbiology laboratories in England and Wales. These are reported on a weekly basis to the Health Protection Agency (HPA) as part of the national surveillance system. We used data extracted from the HPA national surveillance database for influenza and RSV, and for IPD used a reconciled dataset as previously described. In brief, microbiology laboratories in England and Wales report all clinically significant pneumococcal isolates to the HPA through a computerized system (CoSurv). These isolates are often referred to the Respiratory and Vaccine Preventable Bacteria Reference Unit, HPA Microbiology Services for serotyping. These two datasets are then combined and any duplicates are removed. Weekly counts of cases, between 1st January 1996 to 7th June 2009, stratified by age group (0–4 years, 5–14 years, 15–64 years and 65 years and over) were analysed. Average weekly temperatures (in degrees Celsius) and monthly sunshine (in hours) for the UK over the same period were sourced from the UK MET office information.

Statistical analyses

The relationship between the weekly incidence of IPD and viral infections was initially analysed by calculating the Pearson and Spearman's correlation coefficients, for the original and standardized datasets. The data were standardized in order to crudely remove the effect of the concurrent seasonality of the pathogens. For each weekly count, the data were standardized by subtracting the mean and dividing by the standard deviation of the counts for that week over all of the years of the study period (13 years), thus providing a measure of how the incidence for a particular week deviates from the average for that time of year. Three different regression models were investigated (Table 2). Two were additive models (a basic linear regression and an identity-linked negative binomial regression) and one was a multiplicative model (a log-linked negative binomial regression). The negative binomial regression models were applied to account for over-dispersion of the dataset. The dependent variable was the incidence of IPD, with explanatory variables, the incidence of influenza and of RSV. Two additional explanatory variables, the UK mean weekly temperature and monthly hours of sunshine, were investigated in the models to adjust for the common seasonality of the pathogens. The models were applied to all ages and then to each age group individually, as well as to a range of lags (0–4 weeks).
Table 2

Description of regression models, method, log- and identity-linked and their equation.

ModelMethodLinkEquation
1LinearIdentityY = β0 + β1·XFLU + β2·XRSV + β3·XTEMP
2Negative binomialIdentityY = β0 + β1·XFLU + β2·XRSV + β3·XTEMP
3Negative binomialLoglog(Y) = β0 + β1·XFLU + β2·XRSV + β3·XTEMP
We estimated the percentage of IPD cases that could be attributable to influenza and RSV. For the additive models, this was estimated by multiplying the virus' case count with its regression coefficient. This determined the estimated number of cases of IPD attributable to the virus and from which a percentage could be calculated. For the multiplicative model, the percentages of IPD cases attributable to influenza and RSV were estimated by multiplying the virus' case count with its fitted rate ratio (RR), (attributable percentage = case count × (RR-1) × 100). All analyses were carried out with STATA version 11.2 (StataCorp. 2009. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP).

Results

The common seasonal incidence of all three diseases, IPD, influenza and RSV can be clearly seen in this dataset (Fig. 1). Whilst IPD cases are reported all year round, there are distinct increases during winter months. For influenza, there are similarly timed peaks in reported incidence, but with fewer cases out of season. The same is true for RSV, with very few cases reported in the summer months and with large numbers of cases being reported, mainly in infants (Table 1), in the winter. Fig. 2a also displays the strong shared seasonality of the different pathogens. However, in Fig. 2b, where the data have been standardized to remove the effect of the common seasonality, the correlation in the scatter plot is weakened considerably compared to Fig. 2a. The age group with the largest reported incidence of IPD is the over 65 year olds (49.0%). The 0–4 year age group reported the most RSV infections (94.8%). For influenza, most cases were reported in the 15–64 years age group (49.6%).
Figure 1

Time series plots of incidence per 100 000 population of IPD, influenza and RSV, the mean weekly temperature (°C) and monthly sunshine (h), from week 1 (January), 1996 to week 23 (June), 2009.

Table 1

Number (percentage), by age group, of cases of each disease over the study period.

Age groupIPDInfluenzaRSV
0–4 yrs8153 (11.43%)4510 (18.30%)107 525 (94.81%)
5–14 yrs1787 (2.51%)2393 (9.71%)1190 (1.05%)
15–64 yrs26 457 (37.09%)12 209 (49.55%)3079 (2.72%)
65+ yrs34 936 (48.98%)5528 (22.44%)1616 (1.43%)
Total71 33324 640113 410
Figure 2

Scatter plot of (a) weekly incidence of IPD against weekly incidence of viral infection (influenza [LEFT] and RSV [RIGHT]) and (b) the equivalent standardized results; with linear trend lines and 95% confidence intervals.

Pearson and Spearman's correlation coefficients between IPD and both respiratory viruses found strong, significant associations for all age groups (Fig. 3): all coefficients have a P-value <0.001. In most age groups, the correlation coefficients are higher for RSV than for influenza. Both coefficients are highest in the older age groups, with the 65 years and over having the strongest correlation for IPD and influenza and similarly strong associations for IPD and RSV.
Figure 3

Pearson and Spearman's correlation coefficients for all ages and each age group for IPD and influenza and IPD and RSV (all coefficients have P-values <0.001).

In the multivariate regression analyses, the factor responsible for the strongest associations with IPD is found to be the average temperature as opposed to either of the viral infections or hours of sunshine (Tables 3 and 4). There was no evidence of an association between IPD and hours of sunshine (results not shown). There was, however, some evidence of an association between IPD and one month lagged hours of sunshine (Table 4). For the age group of all ages, the strongest viral association is with influenza, followed by RSV, for all of the regression techniques. There is no evidence of any significant time lags in the incidence data (i.e. model fit did not improve with the introduction of any lags of 1–4 weeks).
Table 3

Linear regression, negative binomial regression with an identity link and with a log link for each age group with temperature as a meteorological variable.

AgeVariableAdditive
Multiplicative
Linear Reg.
N. Binomial Reg. with identity link
N. Binomial Reg. with log link
CoefficientP-valueCoefficientP-valueCoefficientP-value
All ages‘Flu0.262<0.0010.285<0.0010.002<0.001
RSV0.032<0.0010.029<0.0010.0000.001
Temp.−4.711<0.001−4.664<0.001−0.060<0.001
Constant136.102<0.001135.279<0.0015.095<0.001



0–4 yrs‘Flu−0.0040.7710.0040.787−0.0010.577
RSV0.0020.0460.0020.0320.0000.135
Temp.−0.613<0.001−0.630<0.001−0.060<0.001
Constant17.746<0.00117.848<0.0013.024<0.001



5–14 yrs‘Flu0.0330.0230.0320.0760.0090.090
RSV0.132<0.0010.1090.0010.0340.001
Temp.−0.084<0.001−0.094<0.001−0.043<0.001
Constant3.081<0.0013.227<0.0011.246<0.001



15–64 yrs‘Flu0.0920.0020.0710.0640.0010.098
RSV1.853<0.0011.640<0.0010.032<0.001
Temp.−1.158<0.001−1.401<0.001−0.048<0.001
Constant40.006<0.00143.771<0.0013.896<0.001



65+ yrs‘Flu0.340<0.0010.406<0.0010.004<0.001
RSV2.647<0.0012.502<0.0010.034<0.001
Temp.−2.407<0.001−2.298<0.001−0.062<0.001
Constant65.960<0.00164.553<0.0014.366<0.001
Table 4

Linear regression, negative binomial regression with an identity link and with a log link for each age group with monthly lagged hours of sunshine as a meteorological variable.

AgeVariableAdditive
Multiplicative
Linear Reg.
N. Binomial Reg. with identity link
N. Binomial Reg. with log link
CoefficientP-valueCoefficientP-valueCoefficientP-value
All ages‘Flu0.226<0.0010.349<0.0010.000<0.001
RSV0.0300.0060.0330.0050.0000.013
Sun−1.655<0.001−1.320<0.001−0.004<0.001
Constant577.816<0.001519.261<0.0016.456<0.001



0–4 yrs‘Flu−0.0040.8790.0130.5710.0000.832
RSV0.0020.2930.0020.2550.0000.415
Sun−0.213<0.001−0.213<0.001−0.005<0.001
Constant74.342<0.00173.834<0.0014.427<0.001



5–14 yrs‘Flu0.0600.0140.0660.0290.0040.017
RSV0.1490.0080.1470.0050.0100.010
Sun−0.0150.235−0.0180.084−0.0020.036
Constant10.881<0.00111.165<0.0012.500<0.001



15–64 yrs‘Flu0.0430.4140.0940.1570.0000.407
RSV2.396<0.0012.752<0.0010.011<0.001
Sun−0.2370.050−0.1680.059−0.003<0.001
Constant142.349<0.001125.034<0.0015.105<0.001



65+ yrs‘Flu0.2040.0100.4470.0060.0010.079
RSV3.800<0.0014.509<0.0010.013<0.001
Sun−0.692<0.001−0.503<0.001−0.004<0.001
Constant251.428<0.001215.461<0.0015.633<0.001
The linear regression model adjusted by weekly temperature indicates that 6.9% of IPD cases are attributable to influenza and 3.9% attributable to RSV, for all ages (Table 5). The results using the additive negative binomial model are similar (7.5% attributable to influenza and 3.5% attributable to RSV) and the results from the multiplicative negative binomial model are slightly lower than the additive models (5.6% attributable to influenza and 2.9% attributable to RSV). For the linear model adjusted by lagged monthly sunshine, 6.1% of IPD cases were attributable to influenza and 3.8% attributable to RSV, for all ages (Table 6). The percentage is higher for the additive negative binomial model (9.2% attributable to influenza and 4.1% attributable to RSV) and lower for the multiplicative negative binomial model (5.7% attributable to influenza and 3.4% attributable to RSV). The multiplicative model tends to predict a lower percentage of attributable IPD cases to influenza and RSV in all of the age groups.
Table 5

Percentage of IPD cases attributable to influenza and RSV for the two additive models; linear regression model and negative binomial regression model with identity-link (additive) and with log-link (multiplicative) with temperature as a meteorological variable.

AgeAttributable toLinear regression
Additive negative binomial regression
Multiplicative negative binomial regression
%Std deva95% CIb%Std deva95% CIb%Std deva95% CIb
All agesInfluenza6.8888.1140.46126.3127.4618.6890.50328.1315.5578.7450.15823.806
RSV3.8925.7340.16717.7313.5255.2350.15016.1752.9404.7790.05414.208



0–4 yrsInfluenza−0.1980.410−0.9320.0000.1840.3740.0000.868−0.3730.785−1.7930.000
RSV1.7642.7660.0388.3381.9563.0520.0449.1751.4182.3640.0186.949



5–14 yrsInfluenza3.4935.1660.00014.7823.3594.9750.00014.1712.9195.1030.00013.644
RSV6.5989.1600.00026.8985.5487.8150.00022.8495.8679.4150.00027.568



15–64 yrsInfluenza3.4414.0050.19712.5522.6673.1500.1519.9411.8312.7700.1057.441
RSV16.71213.8980.00044.12414.91112.6090.00040.07814.51417.1380.00052.721



65+ yrsInfluenza4.0475.5930.00016.3284.7816.5020.00019.1763.2266.3060.00014.687
RSV9.5149.3650.00028.4689.0538.9620.00027.2227.90510.2360.00027.356

Standard deviation.

95% confidence interval.

Table 6

Percentage of IPD cases attributable to influenza and RSV for the two additive models; linear regression model and negative binomial regression model with identity-link (additive) and with log-link (multiplicative) with monthly lagged hours of sunshine as a meteorological variable.

AgeAttributable toLinear regression
Additive negative binomial regression
Multiplicative negative binomial regression
%Std deva95% CIb%Std deva95% CIb%Std deva95% CIb
All agesInfluenza6.1276.9250.72319.9079.2339.9071.17229.0125.7408.4620.41423.312
RSV3.7515.2840.19316.4574.1225.8240.21317.7893.3935.2200.09615.328



0–4 yrsInfluenza−0.1840.348−0.7170.0000.5621.0300.0002.210−0.2210.423−0.9170.000
RSV1.5802.3680.0527.0661.6122.4090.0557.2151.2131.9130.0245.638



5–14 yrsInfluenza6.3778.1420.00023.7306.8998.6730.00025.3935.6868.8490.00023.850
RSV7.9449.5310.00029.0747.7249.2670.00028.3607.60010.6240.00034.290



15–64 yrsInfluenza1.6551.8810.2185.8883.5813.8960.49312.4171.4081.9900.1124.918
RSV22.21215.8832.22853.66525.08517.1462.65858.15520.82622.6601.09173.080



65+ yrsInfluenza2.5333.2950.2429.4165.3226.4290.54519.1292.2133.9850.1298.642
RSV14.12010.7920.00035.42616.57412.3300.00040.38612.97714.2890.00042.692

Standard deviation.

95% confidence interval.

For RSV, the lowest percentage of attributable cases is in the 0–4 year olds (1–2%, dependent on the model) and the highest percentage is in the 15–64 year olds (15–25%). The percentages of attributable IPD cases increase across all age groups and in all models. The percentage of influenza-attributable cases increased with age from 0 to 6%. The percentage of cases attributable to RSV ranged from 3 to 28% with the highest percentage being for the 15–64 years group.

Discussion

We have found a small but statistically significant association between invasive pneumococcal disease and viral infections after accounting for the common seasonality of the infections. Influenza-attributable IPD accounted for between 0 and 9.2% of cases of IPD according to age, meteorological variable and regression method used. In the additive negative binomial regression model, 7.5% of IPD is attributable to influenza, for all ages, when adjusted by average temperature (best-fitting model). The percentage of RSV-associated IPD accounted for between 1.5 and 25% of all IPD cases, with 3.5% of IPD attributable to RSV, for all ages, when adjusted by average temperature in the additive negative binomial regression model. Our results for influenza are in line with those of other studies applying similar techniques. They found influenza was associated with 6–10% and 5–6% of IPD cases. Our study is the first, to our knowledge, to estimate the IPD cases attributable to both influenza and RSV, in different age groups and including average temperature and hours of sunshine to allow for the seasonal characteristics of the data. Our study has looked in more detail at the influence of age in associations between IPD and viral infections. We found that for influenza the attributable percentage of IPD cases is lowest in the 0–4 years group for both meteorological variables (∼0%) and highest in the over 65 years group when adjusted by temperature (3.2–4.8%, dependent on the model) or highest in the 5–14 years group when adjusted by hours of sunshine (5.7–6.9%). For RSV, the attributable percentage of IPD cases was again lowest in the 0–4 years group for both meteorological variables (1–2%) and highest in the 15–64 years group for both variables (14.5–25%). In previous studies, evidence of associations between influenza and IPD has been more consistently reported in adults compared to children where the associations are weaker or non-existent. We also found that the associations between IPD and influenza were stronger in older age groups when adjusted by temperature. This was not the case when adjusted by hours of sunshine. However the data on hours of sunshine is only available at monthly time periods as opposed to weekly temperature measurements and the association between IPD and temperature was found to be stronger than that between IPD and sunshine (where all data was converted to monthly time periods). In the case of IPD and RSV in children, most studies have found the association between IPD and RSV was stronger than that of IPD and influenza, with only Talbot et al. finding the reverse result. Our study also estimates that more cases of IPD in children are attributable to RSV than influenza; however the strength of the statistical evidence of our results for influenza is weak. We also found a similar result for adults. Whether the average air temperature and hours of sunshine are merely markers of some other underlying process or whether they do truly affect the transmissibility, severity or duration of infection is still debated. However, due to the relative strength of the evidence that average temperature and hours of sunshine, are associated with IPD and viral infections it was determined that they were a logical choice to account for seasonality. We found a 1 month lag in the association between IPD and hours of sunshine, consistent with three other studies reporting lags of 2–5 weeks though no lag was reported in 2 other studies. This may be related to the strong, positive effects of sunlight on the immune system due to increased 1,25-(OH)2-vitamin-D metabolism. Other meteorological factors such as rainfall and relative humidity were not included in the models as associations with IPD and viral infections are less consistent. It may be that the use of average temperature as an adjustment for seasonality has led to slightly lower percentages, for some age-groups, of influenza-attributable IPD when compared to previous studies which included seasonal harmonic curves. However, the use of harmonic curves does not allow for annual variations. From our results using Pearson and Spearman's correlation coefficients, we could conclude that there is a very strong association between IPD and the viral infections; however these are rather crude measures of association that cannot be seasonally adjusted, and so are likely to overestimate any association in our data. Further analysis, beyond the use of correlation coefficients, should be considered in similar studies of seasonal diseases in order to formulate more robust conclusions. We investigated a range of regression models; looking at both additive and multiplicative models. It is considered that the additive model is a more plausible fit for this biological data, a multiplicative relationship between the independent variable terms in the model would be hard to substantiate. However, it is difficult to firmly conclude which model is the best as we have no gold standard for comparison (see ref and below). The ecological nature of this study restricts the conclusions that can be drawn. Research at an individual level may be more revealing with respect to the true incidence of virus-attributable IPD, but will be more challenging. Potential study designs that could be employed include case-control studies of IPD with serological investigations of recent viral infections. There are further limitations in the use of surveillance systems for the data in this study, under-reporting and changes over time in the reporting thresholds cannot be ruled out. The lack of distinction between the strains and serotypes of the diseases could mask any true associations between IPD and the viral infections, if the association only applies to a subgroup of the strains or serotypes. There are important issues with the statistical methods used to gauge the associations, other studies have found, as we have, that the different methods produce variable results. Moreover, negative binomial regression requires assumptions to be made about the data; the observations should be independent and the virulence of the viruses should remain constant. The possible mechanisms underlying the interaction between S. pneumoniae and influenza and RSV have been reviewed by Bosch et al. A primary host defence to infection is the secretion of a mucus layer in the upper respiratory tract. Bacteria bind to the mucus enabling them to be cleared by the action of cilia cells. However, primary viral infection destroys these epithelial cells through metabolic exhaustion or lysis reducing mucus and bacterial clearance. This enables bacteria to progress further into the respiratory tract by inhalation or adherence to exposed cell surface receptors. Viral factors produced by influenza and RSV also increase bacterial adherence. Influenza produces neuraminidase (NA), which cleaves sialic acids exposing bacterial receptors and thus increasing adherence. RSV expresses RSV-protein G which acts directly as a bacterial receptor. Viral infection may alter behaviour of the immune system, by modifying the expression of antimicrobial peptides and adhesion proteins, these act as receptors for immune cells, however S. pneumoniae and other bacteria have been shown to adhere to these proteins as well. Influenza virus is also known to impair neutrophil function and increase apoptosis, decrease oxidative burst and reduce production and activity of cytokines. The time period of our analysis covers only seasonal influenza and excludes the H1N1swine flu’ pandemic. We censored our dataset at the week preceding the World Health Organization's (WHO) declaration of the pandemic on 11th June 2009 because the UK surveillance systems were modified and enhanced during the pandemic, making direct comparisons with previous time periods difficult. During the second wave of the pandemic in winter 2010/2011, linkage between influenza and invasive bacterial infection surveillance reports suggested that between 6 and 11% (depending on age, with the highest percentage in the 15–44 year age group) of IPD cases had concurrent influenza. This is broadly consistent with our findings. We suggest that there is a small, but measurable association between IPD and RSV and influenza. These results are relevant for public health policy decision making. Prevention of viral respiratory infections may offer some additional benefit in terms of reducing invasive pneumococcal infections and prevention of pneumococcal infections during, say, influenza pandemics could see a reduction in hospitalizations and mortality. There would be merit in considering both IPD and viral infections when looking at interventions for any one of these infections and this could be explored using modelling techniques.
  51 in total

1.  Comparison of the incidence of influenza in relation to climate factors during 2000-2007 in five countries.

Authors:  Julian W Tang; Florence Y L Lai; P Nymadawa; Yi-Mo Deng; Mala Ratnamohan; Martin Petric; Tze Ping Loh; Nancy W S Tee; Dominic E Dwyer; Ian G Barr; Felix Y W Wong
Journal:  J Med Virol       Date:  2010-11       Impact factor: 2.327

Review 2.  The effect of environmental parameters on the survival of airborne infectious agents.

Authors:  Julian W Tang
Journal:  J R Soc Interface       Date:  2009-09-22       Impact factor: 4.118

3.  Increase in invasive Streptococcus pyogenes and Streptococcus pneumoniae infections in England, December 2010 to January 2011.

Authors:  K Zakikhany; M A Degail; T Lamagni; P Waight; R Guy; H Zhao; A Efstratiou; R Pebody; R George; M Ramsay
Journal:  Euro Surveill       Date:  2011-02-03

4.  Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States.

Authors:  Nicholas D Walter; Thomas H Taylor; David K Shay; William W Thompson; Lynnette Brammer; Scott F Dowell; Matthew R Moore
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

5.  The need for validation of statistical methods for estimating respiratory virus-attributable hospitalization.

Authors:  Rodica Gilca; Gaston De Serres; Danuta Skowronski; Guy Boivin; David L Buckeridge
Journal:  Am J Epidemiol       Date:  2009-08-13       Impact factor: 4.897

6.  Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae.

Authors:  Lynnelle A Pittet; Luanne Hall-Stoodley; Melanie R Rutkowski; Allen G Harmsen
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-11       Impact factor: 6.914

7.  Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006.

Authors:  Caroline L Trotter; Pauline Waight; Nick J Andrews; Mary Slack; Androulla Efstratiou; Robert George; Elizabeth Miller
Journal:  J Infect       Date:  2009-12-23       Impact factor: 6.072

8.  Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States.

Authors:  Lone Simonsen; Robert J Taylor; Yinong Young-Xu; Michael Haber; Larissa May; Keith P Klugman
Journal:  mBio       Date:  2011-01-25       Impact factor: 7.867

9.  Evaluation of coseasonality of influenza and invasive pneumococcal disease: results from prospective surveillance.

Authors:  Stefan P Kuster; Ashleigh R Tuite; Jeffrey C Kwong; Allison McGeer; David N Fisman
Journal:  PLoS Med       Date:  2011-06-07       Impact factor: 11.069

10.  Public health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) in the context of the annual influenza epidemic and a severe influenza pandemic.

Authors:  Jaime L Rubin; Lisa J McGarry; Keith P Klugman; David R Strutton; Kristen E Gilmore; Milton C Weinstein
Journal:  BMC Infect Dis       Date:  2010-01-21       Impact factor: 3.090

View more
  17 in total

1.  Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.

Authors:  Sergi Hernández; Carmen Muñoz-Almagro; Pilar Ciruela; Núria Soldevila; Conchita Izquierdo; Maria Gemma Codina; Alvaro Díaz; Fernando Moraga-Llop; Juan José García-García; Ángela Domínguez
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

2.  Respiratory syncytial virus infection in older adults: an under-recognized problem.

Authors:  Angela R Branche; Ann R Falsey
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

3.  The high burden of pneumonia on US emergency departments during the 2009 influenza pandemic.

Authors:  Wesley H Self; Marie R Griffin; Yuwei Zhu; William D Dupont; Tyler W Barrett; Carlos G Grijalva
Journal:  J Infect       Date:  2013-10-15       Impact factor: 6.072

4.  Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data.

Authors:  Daniel M Weinberger; Keith P Klugman; Claudia A Steiner; Lone Simonsen; Cécile Viboud
Journal:  PLoS Med       Date:  2015-01-06       Impact factor: 11.069

5.  Invasive pneumococcal disease rates linked to meteorological factors and respiratory virus circulation (Catalonia, 2006-2012).

Authors:  Pilar Ciruela; Sonia Broner; Conchita Izquierdo; Sergi Hernández; Carmen Muñoz-Almagro; Roman Pallarés; Mireia Jané; Angela Domínguez
Journal:  BMC Public Health       Date:  2016-05-13       Impact factor: 3.295

6.  Burden of Respiratory Syncytial Virus Associated Severe Pneumonia in Hospitalized Children.

Authors:  Madhusha Gonapaladeniya; Thushari Dissanayake; Guwani Liyanage
Journal:  Int J Pediatr       Date:  2021-06-30

Review 7.  The role of respiratory viruses in the etiology of bacterial pneumonia: An ecological perspective.

Authors:  Kyu Han Lee; Aubree Gordon; Betsy Foxman
Journal:  Evol Med Public Health       Date:  2016-02-15

8.  Does Viral Co-Infection Influence the Severity of Acute Respiratory Infection in Children?

Authors:  Miriam Cebey-López; Jethro Herberg; Jacobo Pardo-Seco; Alberto Gómez-Carballa; Nazareth Martinón-Torres; Antonio Salas; José María Martinón-Sánchez; Antonio Justicia; Irene Rivero-Calle; Edward Sumner; Colin Fink; Federico Martinón-Torres
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

9.  Epidemiology, Seasonality and Treatment of Hospitalized Adults and Adolescents with Influenza in Jingzhou, China, 2010-2012.

Authors:  Jiandong Zheng; Xixiang Huo; Yang Huai; Lin Xiao; Hui Jiang; John Klena; Carolyn M Greene; Xuesen Xing; Jigui Huang; Shali Liu; Youxing Peng; Hui Yang; Jun Luo; Zhibin Peng; Linlin Liu; Maoyi Chen; Hui Chen; Yuzhi Zhang; Danqin Huang; Xuhua Guan; Luzhao Feng; Faxian Zhan; Dale J Hu; Jay K Varma; Hongjie Yu
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

Review 10.  Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease.

Authors:  Antoni Torres; Francesco Blasi; Nathalie Dartois; Murat Akova
Journal:  Thorax       Date:  2015-07-28       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.